Screening And Education For Prevention Of Cervical Cancer At Kupu Health Center, Tegal District
DOI:
https://doi.org/10.61978/medicor.v1i1.3Keywords:
Cervical Cancer, VIA Examination, Public Health, Community EducationAbstract
Cervical cancer, or what is often referred to as cervical cancer, is one of the most common types of cancer in the gynecological cancer category throughout the world. Education about cervical cancer and the implementation of VIA examinations have a very important role in increasing public awareness of the importance of maintaining cervical health and encouraging early detection of cervical cancer disorders. This outreach activity provides accurate information about cervical cancer, how important it is to maintain cervical health, as well as factors that can influence the risk of developing cervical cancer. In addition, examination using the IVA method makes it possible to carry out an objective evaluation of the condition of each individual's cervix. By increasing public knowledge and understanding of the importance of cervical health, it can encourage the implementation of appropriate preventive measures, such as undergoing regular VIA examinations, avoiding risk factors that can increase the risk of cervical cancer, and supporting early detection efforts. Early detection of cervical cancer through IVA examination allows early identification of cervical disease, so that treatment can be started early to control and slow the progression of the disease. VIA counseling and examination in the context of cervical cancer prevention is a long-term investment in improving people's quality of life and reducing the burden of cervical cancer in society as a whole.
References
Aga, S. S., Yasmeen, N., & Khan, M. A. (2022). Cervical Cancer and Its Screening: Assessing the Knowledge, Awareness, and Perception among Health and Allied Students. Education Research International, 2022, 1–17. https://doi.org/10.1155/2022/4608643
American Cancer Society. (2020a). Can Cervical Cancer Be Prevented? United States: American Cancer Society.
American Society of Clinical Oncology (ASCO). (2022). Cervical Cancer: Screening and Prevention. United States: American Society of Clinical Oncology (ASCO).
Aoki, E. S., Yin, R., Li, K., Bhatla, N., Singhal, S., Ocviyanti, D., … Termrungruanglert, W. (2020). National screening programs for cervical cancer in Asian countries. Journal of Gynecologic Oncology, 31(3), e55. https://doi.org/10.3802/jgo.2020.31.e55
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394–424. https://doi.org/10.3322/caac.21492
David, J., Joshi, V., Jebin Aaron, D., & Baghel, P. (2022). A Comparative Analysis of Visual Inspection With Acetic Acid, Cervical Cytology, and Histopathology in the Screening and Early Detection of Premalignant and Malignant Lesions of the Cervix. Cureus, 14(9), e29762. https://doi.org/10.7759/cureus.29762
Destra, E., Anggraeni, N., Prakoso, A. B., Ashil, R. H., Jamaludin, J., & Juliastina, M. J. (2023). SCREENING AND EDUCATION FOR THE PREVENTION OF THREADS BUTTERFLY HEALTH CENTER AT SDN 01 LAWATAN TEGAL DISTRICT.Community Service Journal, 2(2), 01–08. https://doi.org/10.54066/abdimas.v2i2.287
Central Java Provincial Health Service. (2021).Central Java Health Profile 2021. Central Java: Central Java Provincial Health Service.
Central Java Provincial Health Service. (2022).Central Java Health Profile Data for 2022. Central Java: Central Java Provincial Health Service.
Fowler, J. R., Maani, E. V., Dunton, C. J., & Jack, B. W. (2022). Cervical Cancer. Treasure Island (FL): StatPearls Publishing.
Global Burden of Cancer Study (Globocan). (2020). South-Eastern Asia. Geneva: World Health Organization.
Ministry of Health of the Republic of Indonesia. (2019).How to Prevent Cervical Cancer? Indonesia: Ministry of Health of the Republic of Indonesia.
Ministry of Health of the Republic of Indonesia. (2021a).Get to know the risk factors for cervical cancer. Indonesia: Ministry of Health of the Republic of Indonesia.
Lohiya, A., Daniel, R. A., Kumar, D., Varghese, C., Rath, R. S., S A, R., & Nongkynrih, B. (2022). Effectiveness of Visual Inspection with Acetic Acid (VIA) Screening on Cervical Cancer Mortality and Incidence - A Systematic Review and Meta-Analysis. Asian Pacific Journal of Cancer Prevention : APJCP, 23(2), 399–407. https://doi.org/10.31557/APJCP.2022.23.2.399
Basic Health Research (Riskesdas). (2018).Women are at Risk of Cervical Cancer. Indonesia: Ministry of Health of the Republic of Indonesia.
The Lancet Regional Health – Southeast Asia. (2023). Cancer in southeast Asia: can we do better? The Lancet Regional Health - Southeast Asia, 12, 100216. https://doi.org/10.1016/j.lansea.2023.100216
World Heatlh Organization. (2022). Cervical Cancer. Geneva: World Health Organization.
Zhang, S., Xu, H., Zhang, L., & Qiao, Y. (2020). Cervical cancer: Epidemiology, risk factors and screening. Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu, 32(6), 720–728. https://doi.org/10.21147/j.issn.1000-9604.2020.06.05
Akpan, M. I., Ndep, A. O., Ekpenyong, B. N., Akpan, I. A., Akpan, A. I., Eyam, L. E., Ella, R. E., & Ekanem, E. E. (2023). Cervical cancer screening services targeting adult women in Cross River State, Nigeria. African Journal of Reproductive Health, 27(4), 34–42. https://doi.org/10.29063/ajrh2023/v27i4.4
Boyce-Fappiano, D., Nguyen, K. A., Gjyshi, O., Manzar, G., Abana, C., Klopp, A., Kamrava, M., Orio, P. F., Thaker, N. G., Mourtada, F., Venkat, P., & Chang, A. J. (2021). SPECIAL SERIES: RADIATION ONCOLOGY—ALTERNATIVE PAYMENT MODEL Socioeconomic and Racial Determinants of Brachytherapy Utilization for Cervical Cancer: Concerns for Widening Disparities. JCO Oncology Practice, 17(12), E1958–E1967. https://doi.org/10.1200/OP.21.00291
Castañeda, K. M., Sidorenkov, G. A., de Waard, J., Greuter, M. J. W., van der Vegt, B., de Kok, I. M. C. M., Siebers, A. G., Vermeulen, K. M., Wisman, G. B. A., Schuuring, E., & de Bock, G. H. (2023). The effect of extended participation windows on attendance at cervical cancer screening. Preventive Medicine Reports, 32. https://doi.org/10.1016/j.pmedr.2023.102166
Castellano, T., Moore, K., Ting, J., Washington, C., Yildiz, Y., Surinach, A., Sonawane, K., Chhatwal, J., & Ayer, T. (2023). Cervical cancer geographical burden analyzer: An interactive, open-access tool for understanding geographical disease burden in patients with recurrent or metastatic cervical cancer. Gynecologic Oncology, 169, 113–117. https://doi.org/10.1016/j.ygyno.2022.12.004
Chen, H.-H., Meng, W.-Y., Li, R.-Z., Wang, Q.-Y., Wang, Y.-W., Pan, H.-D., Yan, P.-Y., Wu, Q.-B., Liu, L., Yao, X.-J., Kang, M., & Leung, E. L.-H. (2021). Potential prognostic factors in progression-free survival for patients with cervical cancer. BMC Cancer, 21(1). https://doi.org/10.1186/s12885-021-08243-3
Collarino, A., Florit, A., Bizzarri, N., Lanni, V., Morganti, S., De Summa, M., Vizzielli, G., Fanfani, F., Mirabelli, R., Ferrandina, G., Scambia, G., Rufini, V., Faccini, R., & Collamati, F. (2023). Radioguided surgery with β decay: A feasibility study in cervical cancer. Physica Medica, 113. https://doi.org/10.1016/j.ejmp.2023.102658
Eide, A. J., Halle, M. K., Lura, N., Fasmer, K. E., Wagner-Larsen, K., Forsse, D., Bertelsen, B. I., Salvesen, Ø., Krakstad, C., & Haldorsen, I. S. (2023). Visceral fat percentage for prediction of outcome in uterine cervical cancer. Gynecologic Oncology, 176, 62–68. https://doi.org/10.1016/j.ygyno.2023.06.581
Garcia-Becerra, N., Aguila-Estrada, M. U., Palafox-Mariscal, L. A., Hernandez-Flores, G., Aguilar-Lemarroy, A., & Jave-Suarez, L. F. (2023). FOXP3 Isoforms Expression in Cervical Cancer: Evidence about the Cancer-Related Properties of FOXP3Δ2Δ7 in Keratinocytes. Cancers, 15(2). https://doi.org/10.3390/cancers15020347
Ginocchi, A., Rogan, E. M., & Conley, C. C. (2023). Assessing the Relationship Between Motherhood and Cervical Cancer Screening and Prevention Behaviors. Journal of Women’s Health, 32(4), 494–502. https://doi.org/10.1089/jwh.2022.0388
Guo, M., Qiao, Y., Lu, Y., Zhu, L., & Zheng, L. (2023). Squalene epoxidase facilitates cervical cancer progression by modulating tumor protein p53 signaling pathway. Journal of Obstetrics and Gynaecology Research, 49(5), 1383–1392. https://doi.org/10.1111/jog.15576
Harami, E., Tsironi, M., Prezerakos, P., Agorastos, T., & Ziga, S. (2014). Investigation of women’s knowledge about the prevention of cervical cancer. Archives of Hellenic Medicine, 31(3), 342–351. https://www.scopus.com/inward/record.uri?eid=2-s2.0-84901595913&partnerID=40&md5=26fb179dba4410a5d32172050912b542
Jensen, B., Khan, H., & Layeequr Rahman, R. (2023). Sociodemographic Determinants in Cervical Cancer Screening among the Underserved West Texas Women. Women’s Health Reports, 4(1), 191–201. https://doi.org/10.1089/whr.2022.0050
Kallis, K., Moore, L. C., Cortes, K. G., Brown, D., Mayadev, J., Moore, K. L., & Meyers, S. M. (2023). Automated treatment planning framework for brachytherapy of cervical cancer using 3D dose predictions. Physics in Medicine and Biology, 68(8). https://doi.org/10.1088/1361-6560/acc37c
Kibaara, M., & Degu, A. (2023). Assessment of adverse events among cervical cancer patients at Kenyatta National Hospital. Journal of Oncology Pharmacy Practice, 29(2), 326–332. https://doi.org/10.1177/10781552211068133
Laios, A., Otify, M., Papadopoulou, A., Gallos, I. D., & Ind, T. (2022). Outcomes of ovarian transposition in cervical cancer; an updated meta-analysis. BMC Women’s Health, 22(1). https://doi.org/10.1186/s12905-022-01887-8
le Guyader, M., Lam Cham Kee, D., Thamphya, B., Schiappa, R., Gautier, M., Chand-Fouche, M.-E., & Hannoun-Levi, J.-M. (2022). High-dose-rate brachytherapy boost for locally advanced cervical cancer: Oncological outcome and toxicity analysis of 4 fractionation schemes. Clinical and Translational Radiation Oncology, 32, 15–23. https://doi.org/10.1016/j.ctro.2021.10.005
Li, J., Gong, X., Li, P., Ouyang, X., Chang, X., & Tang, J. (2021). Preoperative Conization May Have a Positive Impact on Survival in Early-Stage Cervical Cancer: A Propensity-Matched Study. Oncology Research and Treatment, 44(12), 710–717. https://doi.org/10.1159/000519646
Lindsay, A. C., Delgado, D., Valdez, M. J., Restrepo, E., & Guzman, Y. M. (2022). “I don’t Think He Needs the HPV Vaccine Cause Boys Can’t Have Cervical Cancer”: a Qualitative Study of Latina Mothers’ (Mis) Understandings About Human Papillomavirus Transmission, Associated Cancers, and the Vaccine. Journal of Cancer Education, 37(2), 370–378. https://doi.org/10.1007/s13187-020-01824-z
Membrilla-Beltran, L., Cardona, D., Camara-Roca, L., Aparicio-Mota, A., Roman, P., & Rueda-Ruzafa, L. (2023). Impact of Cervical Cancer on Quality of Life and Sexuality in Female Survivors. International Journal of Environmental Research and Public Health, 20(4). https://doi.org/10.3390/ijerph20043751
Ning, F., Xin, L., Quan, W., Xiaohui, L., & Xiaoping, D. (2023). A preliminary research on transcultural capacity in global public health: from the view of public health professionals. BMC Public Health, 23(1). https://doi.org/10.1186/s12889-023-15312-8
Nishimura, Y., Matsuura, M., Terada, N., Nagao, S., Shimada, H., Isoyama, K., Tamate, M., Iwasaki, M., & Saito, T. (2023). Mailing human papillomavirus self-sampling kits to women under-screened for cervical cancer improved detection in cervical cancer screening in a general population study in Japan. BMC Public Health, 23(1). https://doi.org/10.1186/s12889-023-15402-7
Olawaiye, A. B., Baker, T. P., Washington, M. K., & Mutch, D. G. (2021). The new (Version 9) American Joint Committee on Cancer tumor, node, metastasis staging for cervical cancer. CA Cancer Journal for Clinicians, 71(4), 287–298. https://doi.org/10.3322/caac.21663
Purwoto, G., Vitantri, F., Purbadi, S., Feharsal, Y., Novianti, L., & Scovani, L. (2022). Recurrence Rate of Cervical Cancer in Jakarta. European Journal of Oncology, 27(1). https://www.scopus.com/inward/record.uri?eid=2-s2.0-85163048037&partnerID=40&md5=9248c99c33d77600b00e8433f2a9933e
Raap, S., Knibbe, M., & Horstman, K. (2023). Making health public: A philosophy cafe in a disadvantaged neighbourhood. Health Promotion International, 38(4). https://doi.org/10.1093/heapro/daab206
Raj, S., Kattepur, A. K., Shylasree, T. S., Mishra, G. A., Patil, A., Pimple, S., Noronha, S., & Pramesh, C. S. (2023). Novel educational training of para medical professionals in cervical cancer screening. Gynecologic Oncology Reports, 48. https://doi.org/10.1016/j.gore.2023.101241
Rod, N. H., Broadbent, A., Rod, M. H., Russo, F., Arah, O. A., & Stronks, K. (2023). Complexity in Epidemiology and Public Health. Addressing Complex Health Problems Through a Mix of Epidemiologic Methods and Data. Epidemiology, 34(4), 505–514. https://doi.org/10.1097/EDE.0000000000001612
Siegel, D. J., & Drulis, C. (2023). An interpersonal neurobiology perspective on the mind and mental health: personal, public, and planetary well-being. Annals of General Psychiatry, 22(1). https://doi.org/10.1186/s12991-023-00434-5
Takimoto, Y., Tsubamoto, H., Taniguchi, R., Sakata, K., Takada, Y., Adachi, J., Tomonaga, T., Ueda, T., Nakagawa, K., Narita, S., Wakimoto, Y., & Shibahara, H. (2023). Itraconazole Repolarizes Tumor-associated Macrophages and Suppresses Cervical Cancer Cell Growth. Anticancer Research, 43(2), 569–580. https://doi.org/10.21873/anticanres.16193
Tao, P., Sun, L., Sun, Y., Wang, Y., Yang, Y., Yang, B., & Li, F. (2022). ISG15 is associated with cervical cancer development. Oncology Letters, 24(4). https://doi.org/10.3892/ol.2022.13500
Teka, B., Yoshida-Court, K., Firdawoke, E., Chanyalew, Z., Gizaw, M., Addissie, A., Mihret, A., Colbert, L. E., Napravnik, T. C., El Alam, M. B., Lynn, E. J., Mezzari, M., Anuja, J., Kantelhardt, E. J., Kaufmann, A. M., Klopp, A. H., & Abebe, T. (2023). Cervicovaginal Microbiota Profiles in Precancerous Lesions and Cervical Cancer among Ethiopian Women. Microorganisms, 11(4). https://doi.org/10.3390/microorganisms11040833
Ye, Y., Li, Z., Kang, S., Yang, Y., Ling, B., Wang, L., Yao, J., Li, P., Wang, X., Gong, S., Fan, H., Kong, Y., Cao, Y., Lang, J., Liu, P., & Chen, C. (2023). Treatment of FIGO 2018 stage IIIC cervical cancer with different local tumor factors. BMC Cancer, 23(1). https://doi.org/10.1186/s12885-023-10801-w
Yuan, L., Lei, H., Zou, D., Wen, B., Li, X., Xu, Q., Wang, Y., & Zhou, Q. (2023). Public health insurance and the risk of cancer-specific mortality in patients with cervical cancer: A Chinese prospective cohort study. Frontiers in Public Health, 11. https://doi.org/10.3389/fpubh.2023.1121548
